BIO Ventures for Global Health combats AMR through R&D in Africa
Antimicrobial resistance (AMR) is a health concern with growing global significance. Through GIA, BVGH is forging global public-private partnerships to catalyze innovative R&D and build research and clinical trial capabilities in LMICs, which are disproportionately affected by AMR. Read More